The Rutgers Robert Wood Johnson Medical School has been chosen as one of about 40 sites to see how well benfotiamine can slow ...

Quanterix Corporation (NASDAQ: QTRX), a company transforming healthcare by accelerating biomarker breakthroughs from discovery to diagnostics, today announced publication of a landmark study in the ...

The pursuit of a cure for Alzheimer's disease is becoming an increasingly competitive and contentious quest, with recent ...

The finger-prick blood test employs a plasma separation card, designed to cut costs and simplify testing procedures.

Researchers have added to a stack of existing evidence that 40 Hz gamma frequencies could help to treat Alzheimer's disease.

Superagers” are people over 80 who are unusually resistant to dementia, with memory and thinking abilities that look more ...

A brand-new paper has just been published that claims to challenge the century-old dogma that Alzheimer’s disease is ...

An international trial involving 1,000 volunteers will aim to detect biomarkers associated with the condition.

Researchers at Wakayama Medical University in Japan have discovered that amyloid-β deposits disrupt the formation of the ...

The trial seeks to find an easier and less expensive way to detect a disease that affects 1 in 9 people over the age of 65.

Cleveland researchers achieve full cognitive recovery in mice, offering new hope for dementia patients.

With Black American men being underrepresented in Alzheimer's disease and Alzheimer's disease related dementias (AD/ADRD) research, a January study published in Alzheimer’s & Dementia offered ...